Karoline Bjarnesdatter Rypdal
- Post doc; PhD
- +47 911 93 598
Education
- Philosophiae Doctor (PhD), University of Oslo, Faculty of Medicine 2022
- Master of Science (MSc), Molecular medicine, Norwegian University of Science of Technology (NTNU) and St Olavs Hospital, 2015
- Bachelor of Science (BSc), Cell and molecular biology, NTNU, 2013
Work record (selected)
- Department engineer at Department of Medical Genetics, Oslo University Hospital (OUH), 2015-2017
- PhD candidate at the Institute for Experimental Medical Research (IEMR), OUS and UiO
- Post doctoral researcher at the KG. Jebsen Centre for Cardiac Biomarkers, UiO and Oslo Center for Clinical Heart Research (Oslo-CCHR), OUS
Awards, committees, memberships
- Early Career Investigator Council Member of the International Society of Heart Research (ISHR) European Section
- Member of the K.G. Jebsen Academy for Young Medical Researchers
- Young Investigator Award, Runner up, Heart Failure Association (HFA) Winter Meeting, Les Diablerets, Switzerland, 2020
- Best poster presentation in 2019 and 2022, Annual Norwegian Symposium on Heart Research, Holmenkollen, Oslo, Norway
- Organization committee member, Nature Masterclass on Scientific Writing, Norwegian PhD School of Heart Research (NORHEART), Stiklestad (2018), Sola (2019) and digital (2021)
- Organization committee member, Center for Heart Failure Reseach (CHFR) Annual Symposium, 2018, 2019
- Lecturer, MF9250 - Methods in Cardiac Research, PhD course, NORHEART, UiO, Spring 2019, 2020, 2022, 2023
- Lecturer, MED3067 – Translational cardiology: from bench to bedside, Professional Programme in Medicine, UiO, Spring 2023
Research areas
- Myocardial fibrosis
- Extracellular matrix regulation in cardiovascular disease
- Molecular mechanisms of heart failure
- Role of ADAMTSL proteins in heart disease
- Genetic basis of cardiomyopathies
- Atrial fibrillation
- Regulation of epicardial adipose tissue in coronary heart disease
Social media
- Instagram account for dissemination of heart research: @Hjerteforsk
Publications 2024
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Matrix Biol (in press)
DOI 10.1016/j.matbio.2024.08.008, PubMed 39214156
Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
Mol Biol Rep, 51 (1), 280
DOI 10.1007/s11033-024-09255-5, PubMed 38324186
Publications 2023
Inflammation and Syndecan-4 Shedding from Cardiac Cells in Ischemic and Non-Ischemic Heart Disease
Biomedicines, 11 (4)
DOI 10.3390/biomedicines11041066, PubMed 37189684
Publications 2022
The small leucine-rich proteoglycan fibromodulin exerts anti-fibrotic effects in cultured human cardiac fibroblasts
Genet Mol Res, 21 (1), 1-15
DOI 10.4238/gmr19007, PublikaID 434
ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload
Commun Biol, 5 (1), 1392
DOI 10.1038/s42003-022-04361-1, PubMed 36539599
Publications 2021
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
Sci Rep, 11 (1), 19757
DOI 10.1038/s41598-021-99032-2, PubMed 34611183
Publications 2019
Diagnostics of Hereditary Connective Tissue Disorders by Genetic Next-Generation Sequencing
Genet Test Mol Biomarkers, 23 (11), 783-790
DOI 10.1089/gtmb.2019.0064, PubMed 31638417
Publications 2018
Whole-exome sequencing for diagnosis of hereditary ichthyosis
J Eur Acad Dermatol Venereol, 32 (6), 1022-1027
DOI 10.1111/jdv.14870, PubMed 29444371
Publications 2016
Extensive sequencing of seven human genomes to characterize benchmark reference materials
Sci Data, 3, 160025
DOI 10.1038/sdata.2016.25, PubMed 27271295